No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1235 |
4. Check minimum number of eventsNone |
1235 |
5. Include endpointsNone |
1235 |
6. Filter based on genotype QC (FinnGen only) |
1201 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D31
- Name in latin
- Neoplasma benignum conjunctivae
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Conjunctiva
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of eye and adnexa
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 9125 | 4799 | 4289 |
| Only index persons | 8425 | 4519 | 3906 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.13 | 0.14 | 0.12 |
| Only index persons | 0.16 | 0.17 | 0.15 |
| Median age at first event (years) | |||
| Whole population | 46.75 | 47.84 | 45.62 |
| Only index persons | 46.86 | 48.15 | 45.37 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1201 | 709 | 492 |
| Unadjusted period prevalence (%) | 0.24 | 0.25 | 0.23 |
| Median age at first event (years) | 54.27 | 52.09 | 57.42 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1235
- Matched controls
- 12350
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
CFC00
NOMESCO Finland
Excision of lesion of conjunctiva
461.2
307.7
336
10
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
4503599627370496.0
307.7
1096
*
CFA20
NOMESCO Finland
Biopsy of conjunctiva
282.0
148.8
149
6
CBB30
NOMESCO Finland
Excision of lesion of eyelid
10.3
116.6
137
148
22400
ICD-8 Finland
Benign neoplasm of eye, Conjunctivae
+∞
105.8
100
*
XCK10
NOMESCO Finland
Photography of fundus of eye
4.5
86.9
247
649
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
7.0
80.7
131
207
CBA10
NOMESCO Finland
Biopsy of eyelid
16.5
70.5
60
38
H11.4
ICD-10 Finland
Other conjunctival vascular disorders and cysts
26.5
66.3
46
18
CF2S4
NOMESCO Finland
Photography of conjunctiva
271.6
51.5
52
*
H11.1
ICD-10 Finland
Conjunctival degenerations and deposits
17.6
43.8
36
21
2243A
ICD-9 Finland
Benign neoplasm of eye, Conjunctiva
+∞
41.9
40
*
CD2S4
NOMESCO Finland
Photography of eye
14.0
40.9
38
28
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.2
39.4
620
3892
H00.1
ICD-10 Finland
Chalazion
4.8
39.1
92
204
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
2.1
33.6
490
2938
H04.10
ICD-10 Finland
Dry eye syndrome
2.8
33.5
198
801
3401
FHL
Removal of local modification or taking a specimen in the operating room
+∞
29.3
28
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.3
29.1
276
1385
CBB00
NOMESCO Finland
Excision of chalazion
8.5
26.2
34
41
Z3229
NOMESCO Finland
Other healthcare associate professional
2.7
23.7
141
568
C69.00
ICD-10 Finland
Malignant tumor of the conjunctiva without histology
106.8
19.6
21
*
H01.0
ICD-10 Finland
Blepharitis
2.6
16.7
98
391
H11.8
ICD-10 Finland
Other specified disorders of conjunctiva
24.8
16.0
22
9
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
4.8
15.2
34
72
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
15.2
469
3345
ZXA00
NOMESCO Finland
Right side
1.7
15.1
341
2241
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.1
14.8
150
760
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.5
14.6
94
392
CAB00
NOMESCO Finland
Anterior orbitotomy with excision of lesion
+∞
14.6
14
*
F29
ICPC
Eye symptom/complaint other
2.2
14.6
134
653
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
5.1
14.4
30
60
Z2221
NOMESCO Finland
Medical doctor
1.7
13.7
339
2274
S01GX01
ATC
cromoglicic acid; ophthalmic
1.8
13.4
246
1518
H10.4
ICD-10 Finland
Chronic conjunctivitis
5.8
13.2
24
42
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
2.4
13.0
96
427
ZXE00
NOMESCO Finland
One hour or less
1.6
12.6
469
3461
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
9.8
12.3
24
25
WX002
NOMESCO Finland
Sedation and analgesia
1.7
12.2
246
1556
ZXD20
NOMESCO Finland
Day surgery
1.9
12.2
169
955
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
4.6
11.9
28
62
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
20.2
11.1
16
8
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
10.9
843
7196
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
5.5
10.9
21
39
N17
ICPC
Vertigo/dizziness
1.9
10.8
155
883
Z3231
NOMESCO Finland
Registered nurse
1.6
10.8
327
2284
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.4
10.7
39
119
XCK00
NOMESCO Finland
Perimetry
2.3
10.6
80
360
S21
ICPC
Skin texture symptom/complaint
1.8
10.4
173
1031
H02.1
ICD-10 Finland
Ectropion of eyelid
5.5
10.4
20
37
H11.9
ICD-10 Finland
Disorder of conjunctiva, unspecified
23.6
10.2
14
6
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
10.0
415
3103
ZXA05
NOMESCO Finland
Left side
1.6
10.0
294
2038
L29
ICPC
Musculoskeletal sympt/complt other
2.0
9.9
106
547
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.0
9.4
105
551
A98
ICPC
Health maint/preventive medicine
2.4
9.0
1185
11209
CFD10
NOMESCO Finland
Repair of conjunctiva
24.2
8.9
12
5
H11.0
ICD-10 Finland
Pterygium
6.7
8.7
21
32
H16.9
ICD-10 Finland
Keratitis, unspecified
3.7
8.6
27
75
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
11.7
8.6
15
13
D31.1
ICD-10 Finland
Benign neoplasm: Cornea
90.7
8.4
9
*
R03AC02
ATC
salbutamol; inhalant
1.4
8.4
635
5269
CBB99
NOMESCO Finland
Other excision or destruction of lesion of eyelid
10.8
8.3
15
14
E0000UV, ,
ATC
1.4
8.3
466
3665
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
7.9
524
4232
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
7.8
329
2444
A02BC02
ATC
pantoprazole; systemic
1.4
7.7
778
6746
TCC10
NOMESCO Finland
Probing of lacrimal canaliculus/duct
8.9
7.6
15
17
H02AB06
ATC
prednisolone; systemic
1.4
7.5
536
4372
L71.9
ICD-10 Finland
Rosacea, unspecified
2.9
7.5
35
125
H16.0
ICD-10 Finland
Corneal ulcer
2.2
7.4
63
298
Z01.2
ICD-10 Finland
Dental examination
1.4
7.4
503
4067
H53.1
ICD-10 Finland
Subjective visual disturbances
2.0
7.3
79
410
R42
ICD-10 Finland
Dizziness and giddiness
1.5
7.2
255
1828
Z71.8
ICD-10 Finland
Other specified counselling
1.4
7.1
341
2593
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.8
7.0
114
674
S01XA18
ATC
ciclosporin; ophthalmic
6.4
6.9
17
27
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.8
6.9
109
639
J01DB01
ATC
cefalexin; oral
1.5
6.9
967
8788
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
13.9
6.9
11
8
S01AA01
ATC
chloramphenicol; ophthalmic
2.1
6.8
60
289
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
6.7
289
2148
R06AX27
ATC
desloratadine; oral
1.4
6.6
309
2332
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
6.6
521
4298
H02.8
ICD-10 Finland
Other specified disorders of eyelid
8.7
6.6
13
15
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
10.1
6.5
12
12
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
3.7
6.5
20
55
XQ845
NOMESCO Finland
Dermatoscopy
3.2
6.5
25
80
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
6.5
398
3150
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.5
6.4
212
1494
H26.4
ICD-10 Finland
After-cataract
1.7
6.3
108
648
S18
ICPC
Laceration/cut
1.4
6.3
512
4230
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
2.0
6.3
70
368
H02.9
ICD-10 Finland
Disorder of eyelid, unspecified
18.1
6.3
9
5
H11.2
ICD-10 Finland
Conjunctival scars
+∞
6.3
6
*
C69.09
ICD-10 Finland
Malignant tumor in conjunctival other or unspecified histology
+∞
6.3
6
*
CFA12
NOMESCO Finland
Resection of conjunctiva
+∞
6.3
6
*
9699/3-C69.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of conjunctiva
+∞
6.3
6
*
J01FA10
ATC
azithromycin; systemic
1.3
6.2
639
5468
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.5
6.2
201
1411
ZXA10
NOMESCO Finland
Bilateral
1.5
6.2
208
1472
N02AX02
ATC
tramadol; systemic, rectal
1.4
6.2
477
3909
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
6.1
249
1832
T15.1
ICD-10 Finland
Foreign body in conjunctival sac
3.2
6.0
23
73
R01AD09
ATC
mometasone; nasal
1.4
6.0
495
4090
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
6.0
746
6555
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
704
5880
1.46
9.44
10.1
8.9
3.95
4.09
e9/l
0.98
618
5157
895
7843
1.51
9.35
8.3
7.5
76.33
78.28
u/l
0.82
844
7368
1036
9418
1.62
8.79
5.3
4.7
1.83
2.03
mu/l
0.83
953
8600
447
3492
1.44
8.22
3.4
3.5
2.36
2.35
mmol/l
0.63
387
3079
1119
10476
1.73
7.26
19.0
16.6
3.96
3.97
mmol/l
0.45
1089
10178
516
4204
1.39
7.21
2.4
2.3
81.89
76.59
nmol/l
3.65
455
3749
362
2787
1.42
6.98
4.0
3.1
0.34
0.48
e6/l
0.70
274
2134
417
3296
1.40
6.91
3.1
3.2
34.83
32.23
u/l
0.37
397
3143
579
4832
1.37
6.89
6.7
5.7
57.30
57.32
%
0.02
544
4535
1185
11318
2.16
6.88
24.8
20.9
6.70
6.71
e9/l
0.07
1153
10996
629
5331
1.37
6.73
6.0
6.2
11.89
11.17
umol/l
0.49
591
5050
1184
11313
2.13
6.73
24.9
21.0
40.33
40.09
%
0.73
1125
10571
529
4364
1.37
6.71
5.2
4.8
35.96
35.52
g/l
1.03
486
4056
1184
11319
2.11
6.62
24.8
20.9
4.50
4.48
e12/l
0.78
1150
11001
1113
10449
1.66
6.58
18.9
16.5
139.66
139.66
mmol/l
0.00
1086
10168
1040
9616
1.52
6.55
15.8
13.2
80.83
80.98
ml/min/173m2
0.08
845
7920
1184
11323
2.11
6.55
24.9
21.0
135.22
135.04
g/l
0.16
1165
11148
387
3047
1.39
6.48
4.1
3.2
17.42
87.30
e6/l
2.58
302
2367
1183
11314
2.08
6.48
24.8
20.9
249.86
250.86
e9/l
0.20
1153
11023
845
7540
1.38
6.35
4.9
4.1
11.03
12.29
mm/h
2.16
781
6947
583
4912
1.35
6.34
7.1
5.9
27.82
27.77
%
0.04
547
4610
552
4615
1.35
6.30
6.5
6.0
1.21
1.21
mmol/l
0.12
499
4194
1074
10018
1.55
6.29
4.6
4.4
4.61
4.66
mmol/l
0.70
984
9278
233
1682
1.47
6.26
3.2
2.7
0.94
1.03
e6/l
0.16
136
959
1089
10194
1.58
6.23
5.3
4.9
2.72
2.75
mmol/l
0.41
1006
9377
595
5046
1.35
6.12
7.3
6.8
1.22
1.21
mmol/l
0.69
510
4273
504
4172
1.35
6.07
2.2
2.0
96.09
95.00
pmol/l
0.19
253
2140
1035
9607
1.48
5.92
4.0
3.9
1.27
1.29
mmol/l
0.41
934
8771
1065
9951
1.51
5.81
4.6
4.3
1.47
1.47
mmol/l
0.04
974
9157
871
7860
1.37
5.76
4.4
4.0
14.87
14.77
pmol/l
0.60
788
7139
253
1885
1.43
5.72
3.1
3.0
2.46
2.45
mmol/l
0.43
225
1662
765
6774
1.34
5.70
5.4
4.5
42.27
2790.91
e6/l
2.13
15
102
1137
10802
1.66
5.54
12.1
10.4
25.50
25.78
u/l
0.25
1104
10418
1084
10188
1.52
5.51
17.0
14.3
22.01
23.82
mg/l
1.08
862
8098
281
2156
1.39
5.34
3.4
2.6
3.48
5.99
e6/l
4.97
252
1944
157
1084
1.51
5.22
4.1
4.2
234.75
250.74
u/l
0.66
150
1024
720
6373
1.31
5.09
3.1
3.0
—
—
—
0
0
462
3872
1.31
4.81
3.9
3.7
41.34
50.12
ng/l
0.21
306
2686
552
4747
1.29
4.71
18.8
15.5
1.35
1.26
inr
1.35
159
1392
752
6743
1.29
4.59
3.2
3.1
46.05
49.03
u/l
0.42
697
6304
170
1229
1.44
4.49
2.2
2.2
213.70
127.96
ug/g
0.87
133
970
1049
9877
1.41
4.49
4.9
4.5
5.92
5.94
mmol/l
0.23
956
8959
258
2013
1.36
4.35
1.6
1.5
2.42
2.43
g/l
0.03
140
1238
521
4482
1.28
4.32
3.3
2.8
119.92
121.68
ug/l
0.04
483
4132
952
8846
1.33
4.28
20.7
16.8
15.08
14.92
%
0.34
945
8680
49
267
1.87
4.04
1.6
1.8
3.07
5.14
iu/l
1.08
15
88
17
58
2.96
4.02
3.1
2.3
—
—
—
0
0
358
2962
1.29
3.96
2.8
3.0
1277.79
1328.14
ng/l
0.10
306
2527
668
5963
1.26
3.95
5.1
4.9
6.63
6.71
mmol/l
0.42
626
5573
306
2489
1.30
3.83
2.3
2.3
—
—
—
0
0
299
2434
1.30
3.71
1.6
1.5
20.23
20.82
nmol/l
0.32
255
2066
157
1164
1.40
3.61
3.1
2.7
6.68
8.13
umol/l
0.70
138
1011
278
2262
1.30
3.44
1.7
1.7
0.84
1.12
mg/l
2.41
196
1727
319
2642
1.28
3.44
2.8
2.7
7425.65
6341.42
umol/l
0.14
284
2313
380
3215
1.26
3.44
2.9
2.5
59.89
84.27
u/l
0.47
351
2988
573
5081
1.24
3.40
4.5
3.7
0.00
0.01
estimate
0.80
106
944
565
5015
1.23
3.29
4.5
3.7
0.00
0.00
estimate
0.50
112
1035
91
622
1.50
3.23
2.8
3.3
4.31
4.55
pmol/l
1.59
82
540
201
1578
1.33
3.22
3.4
2.9
3.03
2.31
e6/l
0.43
107
865
279
2299
1.28
3.11
1.3
1.3
1.82
1.66
u/ml
0.05
68
614
985
9325
1.28
3.01
6.3
5.7
39.35
39.91
mmol/mol
1.27
917
8628
562
5020
1.22
2.98
5.7
5.0
0.00
0.00
estimate
0.50
110
982
16
63
2.56
2.96
1.1
1.4
11.31
14.41
u/l
1.01
16
58
323
2734
1.25
2.84
1.8
1.7
1.37
1.37
mmol/l
0.03
279
2301
75
507
1.51
2.83
1.1
1.0
—
—
—
0
0
96
682
1.44
2.83
2.3
2.5
12.82
20.19
au/ml
—
10
44
233
1901
1.28
2.80
1.9
1.7
1289.07
1202.86
nmol/l
0.39
171
1429
124
925
1.38
2.78
2.5
2.4
152.61
42.93
u/l
0.45
102
786
293
2460
1.25
2.77
4.7
4.3
22.39
21.47
%
0.48
163
1162
361
3105
1.23
2.73
2.1
2.1
189.27
240.87
u/l
0.50
335
2925
309
2621
1.24
2.65
2.4
2.1
3.01
3.03
mg/l
0.06
257
2231
15
62
2.44
2.54
1.3
1.2
—
—
—
0
0
85
604
1.44
2.53
1.6
1.6
—
—
—
0
0
217
1778
1.27
2.52
1.5
1.5
—
—
—
0
0
218
1791
1.26
2.47
3.2
3.0
0.86
0.77
ug/l
0.22
152
1185
213
1747
1.26
2.45
1.3
1.3
30.18
33.93
iu/ml
0.16
66
571
92
671
1.40
2.39
2.3
2.2
11.96
12.88
nmol/l
0.47
79
599
167
1344
1.28
2.25
2.9
2.4
22.77
22.68
%
0.02
140
1148
350
3057
1.20
2.21
5.5
5.0
4.95
2.82
ug/l
0.46
317
2728
87
641
1.38
2.15
1.4
1.2
279.15
206.11
u/ml
0.36
79
583
33
197
1.69
2.13
8.4
6.4
212.80
245.29
iu/ml
—
5
28
37
228
1.64
2.13
2.6
2.2
130.27
128.92
g/l
0.11
26
173
202
1679
1.24
2.08
1.8
1.8
—
—
—
0
0
10
37
2.72
2.07
1.2
1.3
—
—
—
0
0
146
1170
1.28
2.04
1.7
1.8
—
—
—
0
0
313
2726
1.20
2.02
5.6
4.0
0.00
0.01
estimate
1.08
111
951
11
44
2.51
2.01
1.3
2.8
198.00
208.09
u/l
0.16
11
44
144
1158
1.28
1.97
1.7
1.8
—
—
—
0
0
144
1160
1.27
1.94
7.0
8.1
5.12
5.11
kpa
0.03
134
1115
143
1156
1.27
1.88
7.1
8.1
0.78
1.23
mmol/l
0.76
115
922
188
1570
1.23
1.86
2.7
2.4
13.23
13.06
umol/l
0.11
178
1469
43
286
1.52
1.84
1.7
1.3
—
—
—
0
0
143
1160
1.26
1.83
7.0
8.0
12.35
12.24
kpa
0.10
134
1116
195
1638
1.23
1.83
3.0
3.3
0.82
0.81
mmol/l
0.43
180
1535
174
1444
1.24
1.83
2.8
2.4
2.37
2.34
g/l
0.34
167
1342
129
1040
1.27
1.74
7.4
8.5
95.70
95.64
%
0.03
122
1005
55
390
1.43
1.73
1.2
1.2
0.56
1.15
u/ml
—
5
29
49
340
1.46
1.73
2.4
2.9
—
—
—
0
0
19
103
1.86
1.72
1.2
1.2
—
—
—
0
0
13
61
2.14
1.72
3.6
2.2
0.35
0.23
e9/l
0.94
13
55
358
3197
1.17
1.70
3.5
3.1
7.21
7.54
mmol/l
0.75
297
2685
15
75
2.01
1.70
1.0
1.4
—
17.36
—
0
14
38
251
1.53
1.69
1.4
1.3
—
—
—
0
0
135
1099
1.26
1.69
2.1
2.5
1.77
1.81
%
0.13
118
974
11
49
2.26
1.64
1.5
2.9
349.73
1389.12
u/ml
1.45
11
49
35
230
1.54
1.61
2.0
1.6
—
—
—
0
0
13
63
2.07
1.60
3.8
2.2
437.77
658.09
e6/l
0.74
13
55
334
2981
1.17
1.59
3.6
3.3
461.18
313.75
mg/l
0.20
219
1905
93
729
1.30
1.58
1.7
1.6
—
—
—
0
0
6
20
3.01
1.58
1.2
1.0
51.88
25.02
u/ml
—
6
20
7
26
2.70
1.58
1.1
1.0
—
—
—
0
0
10
44
2.28
1.55
1.1
2.2
—
—
—
0
0
46
323
1.44
1.55
1.7
1.7
—
—
—
0
0
118
958
1.26
1.53
8.1
8.9
118.26
120.61
g/l
0.60
113
935
128
1050
1.24
1.52
4.2
4.3
3.46
22.05
ug/l
1.64
104
866
16
86
1.87
1.50
1.4
1.2
2.24
0.88
u/ml
—
9
41
249
2184
1.18
1.48
1.7
1.7
47418264.30
34349459.01
pmol/l
0.10
213
1805
23
140
1.66
1.45
1.3
1.5
—
—
—
0
0
24
148
1.63
1.45
1.1
1.2
3.78
7.35
u/ml
—
9
60
118
965
1.25
1.45
2.5
2.3
0.22
0.21
g/l
0.55
112
909
194
1669
1.19
1.44
1.4
1.3
14.61
12.63
u/ml
0.13
72
648
32
213
1.52
1.41
5.0
3.8
56.38
57.89
%
0.31
32
213
43
305
1.42
1.40
1.9
2.2
91.47
91.03
%
0.05
43
294
43
306
1.42
1.38
1.5
1.5
299.50
281.76
ug/g
0.23
30
176
31
207
1.51
1.36
4.8
3.4
4.28
4.35
e9/l
0.06
31
207
102
827
1.25
1.36
2.7
3.0
199.95
207.83
ng/l
0.05
94
757
11
54
2.05
1.33
1.1
1.0
—
—
—
0
0
27
179
1.52
1.24
1.4
1.6
—
—
—
0
0
97
792
1.24
1.23
4.2
3.8
86.76
84.86
ng/l
0.09
81
694
97
793
1.24
1.22
2.1
2.7
68.85
66.13
ml/min/173m2
0.25
34
333
5
19
2.64
1.21
1.6
1.0
—
—
—
0
0
7
141
0.49
1.21
1.0
1.4
6.11
7.65
mmol/l
—
7
121
99
814
1.24
1.19
2.1
3.1
65.35
66.74
g/l
1.42
91
748
6
26
2.31
1.18
1.7
2.2
—
—
—
0
0
28
190
1.48
1.17
1.1
1.2
286.14
279.86
u/ml
0.04
21
111
10
50
2.01
1.16
1.2
1.2
—
—
—
0
0
114
954
1.21
1.16
2.6
2.2
360.56
372.67
nmol/l
0.25
103
877
5
20
2.51
1.15
1.2
1.3
—
—
—
0
0
24
158
1.53
1.15
1.3
1.5
—
—
—
0
0
80
646
1.25
1.14
3.0
3.7
1.75
1.93
mmol/l
0.12
57
488
42
310
1.37
1.13
1.3
2.8
36.81
37.94
g/l
0.63
37
281
11
196
0.56
1.13
1.7
1.6
—
—
—
0
0
8
40
2.01
1.12
2.4
1.5
4.78
5.18
umol/l
—
8
40
29
201
1.45
1.10
1.1
1.2
—
—
—
0
0
12
67
1.80
1.05
1.1
1.2
—
—
—
0
0
21
138
1.53
1.03
1.4
1.6
—
—
—
0
0
73
594
1.24
0.99
2.4
1.8
—
—
—
0
0
138
1195
1.17
0.99
1.7
1.8
1.55
1.46
%
0.43
122
1047
341
3142
1.12
0.99
4.3
3.8
7.66
9.12
mg/mmol
0.36
220
1972
13
76
1.72
0.99
1.8
1.5
0.87
1.01
g/l
1.45
13
76
21
140
1.51
0.98
1.0
1.1
1.15
1.88
u/ml
0.29
12
66
51
398
1.29
0.97
1.4
1.4
29.60
30.09
iu/l
0.03
41
342
49
381
1.30
0.96
1.7
1.7
7.39
4.75
mg/l
0.25
34
292
43
329
1.32
0.95
1.7
1.8
—
—
—
0
0
43
331
1.31
0.92
2.1
3.0
0.69
0.99
g/l
0.42
38
297
39
296
1.33
0.92
1.3
1.3
251.64
256.93
miu/ml
0.02
16
140
416
3894
1.10
0.89
4.9
3.9
—
—
—
0
0
8
43
1.87
0.87
3.0
4.1
—
—
—
0
0
29
212
1.38
0.87
3.1
2.5
16.33
16.04
%
0.14
18
115
46
361
1.28
0.86
1.3
2.8
3.03
3.00
g/l
0.06
41
332
37
282
1.32
0.86
1.1
1.1
0.64
7.44
u/ml
—
5
32
18
120
1.51
0.85
1.3
1.5
—
—
—
0
0
11
65
1.70
0.82
1.6
1.2
—
—
—
0
0
514
4877
1.09
0.81
2.8
2.5
—
—
—
0
0
33
250
1.33
0.80
1.3
1.1
—
—
—
0
0
27
198
1.37
0.80
1.4
1.6
—
—
—
0
0
58
474
1.23
0.80
2.1
1.7
—
—
—
0
0
10
58
1.73
0.79
1.3
1.6
—
—
—
0
0
10
58
1.73
0.79
1.3
1.6
—
—
—
0
0
38
295
1.30
0.79
1.1
1.2
—
—
—
0
0
149
1327
1.14
0.77
6.6
5.7
1.06
1.04
mmol/l
0.52
141
1227
34
261
1.31
0.77
1.3
1.4
10.59
10.68
u/l
0.01
25
214
100
866
1.17
0.76
2.3
2.4
6.17
7.38
ug/l
0.45
83
762
32
244
1.32
0.76
1.3
1.7
—
—
—
0
0
9
53
1.70
0.75
2.3
1.5
1.26
1.27
nmol/l
—
9
40
71
597
1.20
0.75
1.4
1.4
—
—
—
0
0
11
67
1.65
0.75
1.3
1.5
—
—
—
0
0
210
1917
1.12
0.73
3.5
3.9
700.94
388.05
ng/l
0.36
161
1485
9
55
1.64
0.73
1.2
1.2
191.30
160.02
pmol/l
—
9
55
20
142
1.42
0.72
1.7
1.5
0.92
0.34
nmol/l
0.66
11
108
5
26
1.93
0.70
1.0
1.3
—
—
—
0
0
240
2212
1.11
0.70
4.9
4.0
1.02
1.02
kg/l
0.42
29
318
9
58
1.56
0.70
1.2
1.2
27.89
15.18
u/l
—
9
50
23
169
1.37
0.69
1.1
1.1
2.20
1.56
u/ml
0.28
12
86
17
118
1.45
0.69
1.9
1.4
290.00
279.63
mosm/kgh2o
1.08
11
87
57
474
1.21
0.69
4.5
3.7
24.28
24.11
mmol/l
0.17
57
463
22
161
1.37
0.68
1.2
1.2
—
—
—
0
0
7
42
1.67
0.68
1.0
1.8
—
—
—
0
0
176
1599
1.12
0.68
1.5
1.4
—
—
—
0
0
82
708
1.17
0.66
1.3
1.2
231.41
139.47
iu/ml
0.76
32
283
140
1258
1.13
0.65
6.9
6.9
—
—
—
0
0
7
44
1.59
0.65
1.0
1.1
106.71
94.79
%
—
7
39
7
44
1.59
0.65
1.1
1.5
—
1224630.00
—
0
5
7
44
1.59
0.65
2.0
2.1
9.83
209.95
ug/l
—
7
37
44
359
1.23
0.64
1.3
2.8
10.05
10.29
g/l
0.17
39
329
32
251
1.28
0.64
3.6
2.9
7.90
8.09
kpa
0.31
32
246
40
326
1.23
0.60
1.6
1.5
0.01
20.76
iu/ml
—
7
58
35
281
1.25
0.60
1.5
1.4
—
—
—
0
0
21
157
1.34
0.59
1.2
1.1
—
—
—
0
0
18
131
1.38
0.59
1.1
1.1
—
—
—
0
0
19
140
1.36
0.58
1.1
1.0
1.54
2.02
u/ml
—
7
61
15
106
1.42
0.57
1.0
1.0
0.07
0.65
u/ml
—
5
34
46
384
1.21
0.56
1.3
2.7
3.89
3.60
g/l
1.05
41
356
140
1272
1.11
0.56
4.4
4.5
31.67
32.37
%
0.27
87
859
8
55
1.46
0.56
1.0
1.2
—
—
—
0
0
6
37
1.62
0.55
1.8
1.3
6.42
8.87
ug/l
—
6
37
46
385
1.20
0.55
1.3
2.7
—
—
—
0
0
46
385
1.20
0.55
1.3
2.7
7.42
7.38
g/l
0.06
41
356
99
882
1.13
0.55
6.6
7.5
8.90
9.72
mmol/l
0.69
94
838
24
186
1.30
0.54
1.3
1.7
—
—
—
0
0
9
60
1.50
0.54
1.2
1.2
77.67
78.66
u/l
—
9
53
31
249
1.25
0.54
1.4
1.7
—
—
—
0
0
20
151
1.33
0.54
1.2
1.2
1.57
3.70
u/ml
—
7
43
9
61
1.48
0.53
1.1
1.2
—
—
—
0
0
9
62
1.45
0.53
1.0
1.3
1.61
1.57
g/l
—
9
62
9
62
1.45
0.53
1.1
1.2
—
—
—
0
0
13
91
1.43
0.53
2.2
2.3
—
—
—
0
0
9
132
0.68
0.52
1.2
1.4
—
—
—
0
0
9
132
0.68
0.52
1.2
1.4
—
—
—
0
0
9
134
0.67
0.52
1.2
1.4
—
—
—
0
0
9
134
0.67
0.52
1.2
1.4
—
—
—
0
0
6
40
1.50
0.51
1.3
1.6
—
—
—
0
0
26
206
1.27
0.51
1.0
1.3
—
—
—
0
0
26
206
1.27
0.51
1.0
1.3
—
—
—
0
0
17
225
0.75
0.51
5.1
3.3
1.45
1.55
mmol/l
0.25
17
220
16
118
1.36
0.50
1.4
1.7
—
—
—
0
0
6
41
1.47
0.50
1.0
1.8
—
—
—
0
0
6
41
1.47
0.50
1.2
1.3
—
—
—
0
0
6
41
1.47
0.50
1.0
1.3
—
—
—
0
0
6
41
1.47
0.50
1.0
1.8
—
—
—
0
0
10
67
1.50
0.49
1.5
2.0
—
—
—
0
0
7
45
1.56
0.49
1.0
1.1
1036.00
1820.09
miu/ml
—
7
45
7
45
1.56
0.49
1.7
1.4
—
—
—
0
0
17
223
0.76
0.48
1.4
1.6
—
—
—
0
0
7
111
0.63
0.48
1.4
1.2
—
—
—
0
0
7
49
1.43
0.46
1.1
1.2
—
—
—
0
0
7
49
1.43
0.46
1.1
1.2
—
—
—
0
0
30
246
1.22
0.45
1.9
1.7
7153.76
14287.41
e6/l
1.34
25
187
17
130
1.31
0.44
1.2
1.6
50.33
57.99
%
0.36
12
90
9
131
0.68
0.43
1.2
1.4
—
—
—
0
0
9
131
0.68
0.43
1.2
1.4
—
—
—
0
0
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
5
32
1.56
0.42
1.4
1.6
—
—
—
0
0
24
194
1.24
0.42
1.6
2.0
4.67
5.03
mmol/24h
0.25
19
172
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
58
1.38
0.41
1.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
27
222
1.22
0.41
1.5
1.4
—
—
—
0
0
27
222
1.22
0.41
1.5
1.4
—
—
—
0
0
27
222
1.22
0.41
1.5
1.4
—
—
—
0
0
27
222
1.22
0.41
1.5
1.4
—
—
—
0
0
38
324
1.18
0.40
1.4
1.4
—
—
—
0
0
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
0
18
0.00
0.40
0.0
2.1
—
0.97
—
0
12
93
846
1.11
0.40
4.5
3.8
1.22
1.23
mmol/l
0.55
87
732
16
124
1.29
0.38
1.6
1.4
—
—
—
0
0
37
317
1.17
0.38
1.4
1.4
—
—
—
0
0
9
67
1.35
0.38
1.4
1.3
—
—
—
0
0
12
89
1.35
0.38
1.4
1.4
—
—
—
0
0
48
421
1.15
0.37
1.6
1.9
—
—
—
0
0
9
69
1.31
0.37
1.1
1.6
11.89
13.13
umol/l
—
9
64
18
143
1.26
0.37
1.1
1.1
—
—
—
0
0
49
431
1.14
0.36
4.9
6.2
1.77
1.57
%
0.58
44
408
35
406
0.86
0.36
1.9
1.9
2.17
2.14
ug/l
0.01
29
357
17
135
1.26
0.35
1.0
1.3
—
0.63
nmol/l
—
0
7
6
44
1.37
0.34
2.3
2.4
46.17
45.06
umol/l
—
6
33
35
302
1.16
0.34
2.9
4.2
2.36
1.77
ratio
—
7
27
12
91
1.32
0.34
1.3
1.2
—
—
—
0
0
14
110
1.28
0.31
1.1
1.1
—
—
—
0
0
34
295
1.16
0.31
1.4
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
37
324
1.15
0.31
2.6
2.6
0.31
0.36
u/ml
0.67
21
179
10
75
1.34
0.30
1.4
1.1
—
—
—
0
0
10
75
1.34
0.30
1.4
1.1
—
—
—
0
0
30
259
1.16
0.30
2.9
2.3
140.34
100.21
ug/min
0.19
21
158
11
84
1.31
0.30
1.4
1.6
—
—
—
0
0
17
139
1.23
0.29
1.1
1.1
117.41
114.46
%
0.16
17
127
10
76
1.32
0.28
1.4
1.1
—
—
—
0
0
10
76
1.32
0.28
1.4
1.1
—
—
—
0
0
10
76
1.32
0.28
1.4
1.1
—
—
—
0
0
35
309
1.14
0.27
3.0
4.2
26.71
46.24
mg/l
1.13
30
251
35
309
1.14
0.27
3.0
4.2
38.06
72.88
mg/l
0.98
30
249
27
234
1.16
0.26
1.1
1.4
2.90
9.85
e6/l
1.30
20
183
27
234
1.16
0.26
1.1
1.4
129.95
838.45
e6/l
0.78
21
189
5
74
0.67
0.26
1.0
1.5
75.80
79.35
umol/l
—
5
74
43
387
1.12
0.25
1.5
1.8
—
—
—
0
0
13
105
1.24
0.25
1.2
1.8
—
—
—
0
0
20
170
1.18
0.24
1.4
1.6
—
—
—
0
0
20
170
1.18
0.24
1.4
1.6
—
—
—
0
0
33
293
1.13
0.24
1.4
1.2
—
—
—
0
0
5
38
1.32
0.23
1.2
1.3
—
—
—
0
0
12
97
1.24
0.23
1.2
1.4
56730.00
103769.28
e6/l
—
6
54
34
304
1.12
0.23
1.8
1.6
—
—
—
0
0
11
88
1.25
0.22
2.5
2.3
—
—
—
0
0
5
42
1.19
0.21
1.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
32
287
1.12
0.21
1.3
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
6.3
—
—
—
0
0
22
192
1.15
0.20
4.0
3.8
14.21
32.18
u/ml
2.16
22
187
14
117
1.20
0.20
1.1
1.7
—
—
—
0
0
0
14
0.00
0.20
0.0
3.1
—
0.64
—
0
14
6
50
1.20
0.19
1.0
1.2
165.67
501.00
u/l
—
6
44
113
1076
1.06
0.19
3.6
3.3
—
—
—
0
0
11
90
1.22
0.19
2.9
1.1
—
—
—
0
0
6
52
1.15
0.19
1.0
1.7
—
—
—
0
0
6
52
1.15
0.19
1.0
1.7
—
—
—
0
0
6
53
1.13
0.18
1.2
1.2
—
—
—
0
0
11
132
0.83
0.18
3.7
2.8
105.27
105.43
mmol/l
0.05
11
132
11
132
0.83
0.18
3.7
2.8
4.01
4.04
mmol/l
0.05
11
132
25
279
0.89
0.18
1.1
1.2
—
—
—
0
0
14
119
1.18
0.17
1.5
1.6
—
—
—
0
0
14
119
1.18
0.17
1.5
1.6
—
—
—
0
0
12
142
0.84
0.17
1.2
1.1
—
—
—
0
0
27
243
1.11
0.17
1.6
1.5
—
—
—
0
0
89
846
1.06
0.17
1.6
1.7
—
—
—
0
0
6
76
0.79
0.15
1.2
1.3
—
—
—
0
0
6
78
0.77
0.15
1.0
1.0
—
—
—
0
0
17
150
1.14
0.14
1.5
1.6
—
—
—
0
0
68
648
1.05
0.13
7.6
7.5
24.91
24.59
mmol/l
0.36
61
617
31
334
0.93
0.12
1.9
2.1
21824.81
3229.69
u/l
—
9
147
5
46
1.09
0.09
2.2
1.8
43.60
50.75
ug/l
—
5
46
17
155
1.10
0.09
3.5
5.2
372.83
368.02
umol/l
0.04
12
138
97
998
0.97
0.08
2.2
2.0
—
—
—
0
0
5
63
0.79
0.08
2.0
2.2
—
237.22
—
0
9
8
74
1.08
0.07
2.0
1.6
—
—
—
0
0
13
143
0.91
0.07
1.2
1.1
—
—
—
0
0
34
357
0.95
0.07
1.4
1.8
—
—
—
0
0
107
1094
0.98
0.07
2.3
2.1
—
—
—
0
0
9
88
1.02
0.07
1.7
1.8
—
—
—
0
0
9
102
0.88
0.06
2.1
2.4
—
—
—
0
0
11
100
1.10
0.05
1.0
1.1
—
—
—
0
0
21
220
0.95
0.03
5.0
3.7
30.65
26.35
mg/l
0.23
13
138
10
92
1.09
0.03
1.0
1.0
—
—
—
0
0
10
92
1.09
0.03
1.1
1.6
—
—
—
0
0
10
92
1.09
0.03
1.1
1.6
—
—
—
0
0
10
92
1.09
0.03
1.1
1.6
—
—
—
0
0
11
103
1.07
0.02
1.1
1.1
94.18
93.22
%
0.07
11
94
11
103
1.07
0.02
3.0
3.8
—
—
—
0
0
24
234
1.03
0.00
1.2
1.5
—
—
—
0
0
43
434
0.99
0.00
1.5
1.5
—
—
—
0
0
11
108
1.02
0.00
1.2
1.3
3.18
3.14
ug/l
0.01
11
93
22
222
0.99
0.00
1.2
1.4
—
—
—
0
0
37
372
0.99
0.00
4.4
3.9
1.13
1.34
mmol/l
1.13
32
364
14
139
1.01
0.00
1.1
1.0
—
—
—
0
0
23
229
1.00
0.00
1.5
1.5
—
—
—
0
0
92
922
1.00
0.00
4.8
3.5
1.62
2.03
mmol/l
0.55
83
764
18
177
1.02
0.00
1.3
1.6
—
—
—
0
0
54
537
1.01
0.00
1.7
1.3
—
—
—
0
0
16
165
0.97
0.00
1.3
1.5
—
—
—
0
0
5
50
1.00
-0.00
1.2
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
61
0.98
-0.00
1.2
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
12.71
—
0
7
7
77
0.91
-0.00
1.1
1.3
—
—
—
0
0
5
50
1.00
-0.00
1.2
1.4
—
—
—
0
0
5
49
1.02
-0.00
1.0
1.6
—
—
—
0
0
5
50
1.00
-0.00
2.4
2.7
44680.00
37150.10
ug/l
—
5
50
6
62
0.97
-0.00
1.3
1.7
2.00
5.63
u/field
—
6
45
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_CONJUNCTIVA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_CONJUNCTIVA | 0.859 [0.75, 0.98] | 0.028 |
| Birth year | 0.999 [0.99, 1.01] | 0.882 |
During the follow-up period (1.1.1998 — 31.12.2019), 382 out of 3763 females with CD2_BENIGN_CONJUNCTIVA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_CONJUNCTIVA | 0.942 [0.82, 1.08] | 0.393 |
| Birth year | 0.988 [0.98, 1.0] | 0.015 |
During the follow-up period (1.1.1998 — 31.12.2019), 471 out of 3295 males with CD2_BENIGN_CONJUNCTIVA died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_CONJUNCTIVA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.092% | 0.141% |
| 5 | 0.466% | 1.121% |
| 10 | 1.353% | 2.747% |
| 15 | 2.688% | 5.275% |
| 20 | 5.024% | 8.955% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_CONJUNCTIVA – Benign neoplasm: Conjunctiva
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data